𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk of noncardiac surgery in the months following placement of a drug-eluting coronary stent

✍ Scribed by Johann Auer; Robert Berent; Thomas Weber; Bernd Eber

Book ID
119263936
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
49 KB
Volume
43
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Discontinuation of antiplatelet therapy
Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: A retrospective cohort study
✍ Daniel J. Brotman; Mihir Bakhru; Wael Saber; Ashish Aneja; Deepak L. Bhatt; Kath πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract ## BACKGROUND Drug‐eluting coronary stents (DESs) pose a challenge in the perioperative period. Sirolimus and paclitaxel may inhibit reendothelialization of the traumatized vessel, making it vulnerable to platelet‐mediated thrombosis. Given the anecdotal evidence and case series sugges